Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Mar 5, 2025 3
8-K Mar 5, 2025 8-K
SCHEDULE 13G/A Feb 14, 2025
SCHEDULE 13G/A Feb 14, 2025
SCHEDULE 13G/A Feb 5, 2025
4 Feb 4, 2025 4
4 Feb 4, 2025 4
4 Feb 4, 2025 4
4 Feb 4, 2025 4
4 Feb 4, 2025 4
8-K Dec 12, 2024 8-K
SC 13D/A Dec 3, 2024
SC 13G Nov 22, 2024 SC 13G
SC 13G/A Nov 14, 2024 SC 13G/A
SC 13G/A Nov 14, 2024 SC 13G/A
SC 13G Nov 8, 2024
10-Q Nov 7, 2024 10-Q
8-K Nov 7, 2024 8-K
SC 13G Oct 24, 2024
RW Oct 21, 2024 RW
424B5 Oct 11, 2024 424B5
SC 13G Oct 11, 2024
424B3 Oct 11, 2024 424B3
EFFECT Oct 9, 2024
EFFECT Oct 9, 2024
← Newer Page 7 of 27 · 660 filings Older →